Management of Levofloxacin Induced Anaphylaxis and Acute Delirium in a Palliative Care Setting

被引:9
作者
Ghoshal, Arunangshu [1 ]
Damani, Anuja [1 ]
Salins, Naveen [1 ]
Deodhar, Jayita [1 ]
Muckaden, Mary Ann [1 ]
机构
[1] Tata Mem Hosp, Dept Palliat Med, Bombay, Maharashtra, India
关键词
Delirium; Levofloxacin; Palliative care;
D O I
10.4103/0973-1075.150194
中图分类号
R19 [保健组织与事业(卫生事业管理)];
学科分类号
摘要
Levofloxacin is a commonly prescribed antibiotic for managing chest and urinary tract infections in a palliative care setting. Incidence of Levofloxacin-associated anaphylaxis is rare and delirium secondary to Levofloxacin is a seldom occurrence with only few published case reports. It is an extremely rare occurrence to see this phenomenon in combination. Early identification and prompt intervention reduces both mortality and morbidity. A 17-year-old male with synovial sarcoma of right thigh with chest wall and lung metastasis and with no prior psychiatric morbidity presented to palliative medicine outpatient department with community-acquired pneumonia. He was initiated on intravenous (IV) Ceftriaxone and IV Levofloxacin. Post IV Levofloxacin patient developed anaphylaxis and acute delirium necessitating IV Hydrocortisone, IV Chlorpheneramine, Oxygen and IV Haloperidol. Early detection and prompt intervention helped in complete recovery. Patient was discharged to hospice for respite after 2 days of hospitalization and then discharged home. Acute palliative care approach facilitated management of two life-threatening medical complications in a palliative care setting improving both quality and length of life.
引用
收藏
页码:76 / 78
页数:3
相关论文
共 19 条
[1]   Multicenter, postmarketing assessment of levofloxacin in the treatment of adults with community-acquired pneumonia [J].
Akpunonu, B ;
Michaelis, J ;
Uy, CN ;
Tennenberg, AM ;
Wiesinger, BA ;
Karim, R ;
Marshall, JS ;
Kahn, JB .
CLINICAL INFECTIOUS DISEASES, 2004, 38 :S5-S15
[2]  
American Psychiatric Association, 2013, DIAGNOSTIC STAT MANU, V5th ed., DOI [DOI 10.1176/APPI.BOOKS.9780890425596, 10.1176/appi.books.9780890425596]
[3]  
[Anonymous], 2004, PROD IMF LEV LEV TAB
[4]   SAFETY OF OFLOXACIN - ADVERSE DRUG-REACTIONS REPORTED DURING PHASE-II STUDIES IN EUROPE AND IN JAPAN [J].
BLOMER, R ;
BRUCH, K ;
KRAUSS, H ;
WACHECK, W .
INFECTION, 1986, 14 :S332-S334
[5]   Comparison of side effects of levofloxacin versus other fluoroquinolones [J].
Carbon, C .
CHEMOTHERAPY, 2001, 47 :9-14
[6]   Monitoring sedation status over time in ICU patients - Reliability and validity of the Richmond Agitation-Sedation Scale (RASS) [J].
Ely, EW ;
Truman, B ;
Shintani, A ;
Thomason, JWW ;
Wheeler, AP ;
Gordon, S ;
Francis, J ;
Speroff, T ;
Gautam, S ;
Margolin, R ;
Sessler, CN ;
Dittus, RS ;
Bernard, GR .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2003, 289 (22) :2983-2991
[7]   Levofloxacin-induced delirium:: Diagnostic considerations [J].
Fernandez-Torre, Jose L. .
CLINICAL NEUROLOGY AND NEUROSURGERY, 2006, 108 (06) :614-614
[8]   Levofloxacin-induced delirium [J].
Hakko, E ;
Mete, B ;
Ozaras, R ;
Tabak, F ;
Ozturk, R ;
Mert, A .
CLINICAL NEUROLOGY AND NEUROSURGERY, 2005, 107 (02) :158-159
[9]  
HAYAKAWA I, 1992, ARZNEIMITTEL-FORSCH, V42-1, P363
[10]   INHIBITORY EFFECTS OF QUINOLONES ON DNA GYRASE OF ESCHERICHIA-COLI AND TOPOISOMERASE-II OF FETAL CALF THYMUS [J].
HOSHINO, K ;
SATO, K ;
UNE, T ;
OSADA, Y .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1989, 33 (10) :1816-1818